Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS

被引:33
|
作者
Gungor, Huseyin [1 ]
Ekici, Mehmet [2 ]
Karayigit, Mehmet Onder [3 ]
Turgut, Nergiz Hacer [4 ]
Kara, Haki [1 ]
Arslanbas, Emre [1 ,5 ]
机构
[1] Cumhuriyet Univ, Fac Vet Med, Dept Pharmacol & Toxicol, Sivas 58140, Turkey
[2] Cumhuriyet Univ, Fac Vet Med, Dept Physiol, Sivas 58140, Turkey
[3] Cumhuriyet Univ, Fac Vet Med, Dept Pathol, Sivas 58140, Turkey
[4] Izmir Katip Celebi Univ, Fac Pharm, Dept Pharmacol, Izmir 35620, Turkey
[5] Ataturk Univ, Fac Vet Med, Dept Vet Pharmacol & Toxicol, Erzurum 25240, Turkey
关键词
Zingerone; Pulmonary fibrosis; Antifibrotic effect; Transforming growth factor-beta 1 (TGF-beta 1); Inducible nitric oxide synthase (iNOS); INDUCED LUNG FIBROSIS; NF-KAPPA-B; NITRIC-OXIDE; INJURY; PATHOGENESIS; INHIBITOR; INDUCTION; APOPTOSIS; TOXICITY; GINGER;
D O I
10.1007/s00210-020-01881-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with limited treatment options. Zingerone found in ginger (Zingiber officinale L.) has many pharmacological effects, especially antiinflammatory and antioxidant activity. However, the effect of zingerone on pulmonary fibrosis (PF) is not fully known. The aim of this study was to investigate the effect of zingerone on bleomycin (BLM)-induced PF and its underlying mechanisms. Wistar-albino rats were given single dose of BLM (5 mg/kg, intratracheal) or vehicle (saline). In treatment groups, zingerone (50 and 100 mg/kg, p.o.) was administered orally for 14 days after BLM administration. Rats and lung tissue were weighed to determine lung index. Antioxidant, antiinflammatory effects, and hydroxyproline content of zingerone were determined by ELISA method. Pulmonary inflammation, collagen deposition, and fibrosis score were determined with Hematoxylin-Eosin (HxE) and Masson's trichrome staining. Transforming growth factor-beta 1 (TGF-beta 1) and inducible nitric oxide synthase (iNOS) expressions were detected immunohistochemically. BLM administration increased lipid peroxidation (MDA) and decreased superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity. In addition, BLM caused increased levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in bronchoalveolar lavage fluid (BALF) and accumulation of collagen bundles. Zingerone administration decreased collagen accumulation, TNF-alpha and IL-1 beta levels, MDA level, TGF-beta 1, and iNOS expression and increased SOD and GPx activity. Histopathological findings supported the results. These results show that zingerone (50 and 100 mg/kg) at both doses significantly contributes to healing of PF by improving inflammation, oxidative stress, and histopathological alterations and by affecting TGF-beta 1 and iNOS signaling pathways.
引用
收藏
页码:1659 / 1670
页数:12
相关论文
共 50 条
  • [21] Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway
    Ruan, Hao
    Gao, Shaoyan
    Li, Shuangling
    Luan, Jiaoyan
    Jiang, Qiuyan
    Li, Xiaohe
    Yin, Huijun
    Zhou, Honggang
    Yang, Cheng
    MOLECULES, 2021, 26 (09):
  • [22] Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway
    Gu, Songtao
    Liang, Jingjing
    Zhang, Jianwei
    Liu, Zhichao
    Miao, Yang
    Wei, Yuli
    Li, Shimeng
    Gu, Jinying
    Cui, Yunyao
    Xiao, Ting
    Li, Xiaohe
    Yang, Cheng
    MOLECULES, 2023, 28 (05):
  • [23] Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β
    Li, Xiaohe
    Yu, Haiyan
    Liang, Lu
    Bi, Zhun
    Wang, Yanhua
    Gao, Shaoyan
    Wang, Mukuo
    Li, Hailong
    Miao, Yang
    Deng, Ruxia
    Ma, Ling
    Luan, Jiaoyan
    Li, Shuangling
    Liu, Menghan
    Lin, Jianping
    Zhou, Honggang
    Yang, Cheng
    BIOCHEMICAL PHARMACOLOGY, 2020, 178
  • [24] Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress
    Wang, Dan
    Yan, Zhibin
    Bu, Lili
    An, Chunmei
    Deng, Bochuan
    Zhang, Jianfeng
    Rao, Jing
    Cheng, Lu
    Zhang, Jingying
    Zhang, Bangzhi
    Xie, Junqiu
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 382
  • [25] Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway
    Ruan, Hao
    Lv, Ziwei
    Liu, Shuaishuai
    Zhang, Liang
    Huang, Kai
    Gao, Shaoyan
    Gan, Wenhua
    Liu, Xiaowei
    Zhang, Shanshan
    Helian, Kaiyue
    Li, Xiaohe
    Zhou, Honggang
    Yang, Cheng
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (01) : 44 - 55
  • [26] S-Allylmercaptocysteine attenuates Bleomycin-induced pulmonary fibrosis in mice via suppressing TGF-β1/Smad and oxidative stress pathways
    Li, Chunyan
    Sun, Xiao
    Li, Ang
    Mo, Min
    Zhao, Zhongxi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 79
  • [27] Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway
    Li, Xiaohe
    Wang, Yanhua
    Liang, Jingjing
    Bi, Zhun
    Ruan, Hao
    Cui, Yunyao
    Ma, Ling
    Wei, Yuli
    Zhou, Bingchen
    Zhang, Liang
    Zhou, Honggang
    Yang, Cheng
    PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5808 - 5822
  • [28] Vincamine Ameliorates Epithelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis in Rats; Targeting TGF-β/MAPK/Snai1 Pathway
    Alaaeldin, Rania
    Mohyeldin, Reham H.
    Bekhit, Amany Abdlrehim
    Gomaa, Wafaey
    Zhao, Qing-Li
    Fathy, Moustafa
    MOLECULES, 2023, 28 (12):
  • [29] Inhibitory Effects of Astragaloside IV on Bleomycin-Induced Pulmonary Fibrosis in Rats Via Attenuation of Oxidative Stress and Inflammation
    Yu, Wei-Na
    Sun, Li-Feng
    Yang, Hua
    INFLAMMATION, 2016, 39 (05) : 1835 - 1841
  • [30] Amitriptyline attenuates bleomycin-induced pulmonary fibrosis: modulation of the expression of NF-κβ, iNOS, and Nrf2
    Mai A. Zaafan
    Ahmed R. Haridy
    Amr M. Abdelhamid
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392 : 279 - 286